SYSTEMATIC REVIEW article
Front. Endocrinol.
Sec. Reproduction
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1595232
This article is part of the Research TopicGenetic Implications in Male Infertility and Advances in Assisted Reproductive Technologies: Towards New Diagnostic and Therapeutic PerspectivesView all 3 articles
Impact of the PPOS Protocol on Euploidy Embryo Rates and Reproductive Outcomes in Preimplantation Genetic Testing Cycles:A Systematic Review
Provisionally accepted- Chengdu Women and Children’s Central Hospital, Chengdu, Sichuan Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The success of assisted reproductive technology (ART) relies on the quality of embryos, particularly the euploid status, which is influenced by controlled ovarian hyperstimulation (COH) protocols. In recent years, the progesterone-primed ovarian stimulation (PPOS) protocol has gained popularity due to its potential benefits. However, the impact of PPOS on euploid embryo rates (EER) and reproductive outcomes remains incompletely understood. Therefore, we conducted this review to comprehensively assess this impact by comparing the PPOS with conventional COH protocols in PGT cycles. The results revealed that the PPOS protocol demonstrated comparable EER and reproductive outcomes to conventional COH protocols in the general population. Among patients with a good prognosis, EER and associated reproductive outcomes with PPOS may be less favorable. However, in individuals with a poor prognosis, PPOS showed comparable or even superior outcomes. Additionally, the timing of cycle initiation, whether in the follicular or luteal phase, had no significant impact on clinical outcomes in patients with diverse ovarian responses.
Keywords: Progesterone-Primed Ovarian Stimulation protocol, Preimplantation GeneticTesting, Euploidy Embryo Rate, Reproductive outcomes, Controlled OvarianHyperstimulation
Received: 17 Mar 2025; Accepted: 19 Aug 2025.
Copyright: © 2025 Mei, Wang, Kuang, Lin and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yonghong Lin, Chengdu Women and Children’s Central Hospital, Chengdu, Sichuan Province, China
Fang Wang, Chengdu Women and Children’s Central Hospital, Chengdu, Sichuan Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
